HPO |
HP:0410350 |
Increased urinary fucosylated oligosaccharide |
"An abnormal increase in the concentrationl of small fucosylated oligosaccharides in the urine." [https://orcid.org/0000-0001-9969-8610, PMID:25251875] |
— |
HP:0010471 |
HPO |
HP:0410351 |
Abnormal complex N-glycan level |
"An abnormal concentration of complex N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610] |
— |
HP:0012347 |
HPO |
HP:0410352 |
Increased complex N-glycan level |
"An abnormal increase in the concentration of complex N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0410351 |
HPO |
HP:0410353 |
Decreased complex N-glycan level |
"An abnormal decrease in the concentration of complex N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:21385794] |
— |
HP:0410351 |
HPO |
HP:0410354 |
Increased sialylated N-glycan level |
"An abnormal increase in the concentration of sialylated N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0012349 |
HPO |
HP:0410355 |
Decreased sialylated N-glycan level |
"An abnormal decrease in the concentration of sialylated N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:23430903] |
— |
HP:0012349 |
HPO |
HP:0410356 |
Abnormal high-mannose N-glycan level |
"An abnormal concentration of high-mannose N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610] |
— |
HP:0012347 |
HPO |
HP:0410357 |
Increased high-mannose N-glycan level |
"An abnormal increase in the concentration of high-mannose N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:23928051] |
— |
HP:0410356 |
HPO |
HP:0410358 |
Decreased high-mannose N-glycan level |
"An abnormal decrease in the concentration of high-mannose N-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0410356 |
HPO |
HP:0410359 |
Abnormal core 1 O-glycan level |
"An abnormal in the concentration of core 1 O-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610] |
— |
HP:0012358 |
HPO |
HP:0410360 |
Increased core 1 O-glycan level |
"An abnormal increase in the concentration of core 1 O-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:14578315] |
— |
HP:0410359 |
HPO |
HP:0410361 |
Decreased core 1 O-glycan level |
"An abnormal decrease in the concentration of core 1 O-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0410359 |
HPO |
HP:0410362 |
Decreased O-mannosyl glycans on alpha-dystroglycan |
"Hypoglycosylation of alpha-dystroglycan with O-mannosyl glycans. Alpha-dystroglycan is a functional target of O-mannosyl glycosylation and functional glycosylation of alpha-DG is essential in its interaction with the extracellular matrix." [PMID:21930648] |
— |
HP:0012358 |
HPO |
HP:0410363 |
Increased monosialylated core 1 O-glycan level |
"An abnormal increase in the concentration of monosialylated core 1 O-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:25142811] |
— |
HP:0012362 |
HPO |
HP:0410364 |
Decreased monosialylated core 1 O-glycan level |
"An abnormal decrease in the concentration of monosialylated core 1 O-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0012362 |
HPO |
HP:0410365 |
Increased disialylated core 1 O-glycan level |
"An abnormal increase in the concentration of disialylated core 1 O-glycans on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0012362 |
HPO |
HP:0410366 |
Increased globoside Gb4 level |
"An abnormal increase in the concentration of globoside Gb4." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0004343 |
HPO |
HP:0410367 |
Increased hepatitis A virus antibody level |
"An abnormally increased level of immunoglobulin against hepatitis A virus in the blood." [] |
— |
HP:0010702 |
HPO |
HP:0410368 |
Increased globoside Gb3 level |
"An abnormal increase in the concentration of glycolipid globoside Gb3." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0004343 |
HPO |
HP:0410369 |
Increased hepatitis B virus antibody level |
"An abnormally increased level of immunoglobulin against hepatitis B virus in the blood." [] |
— |
HP:0010702 |
HPO |
HP:0410370 |
Absence of ganglioside GM3 |
"The absence of ganglioside GM3." [https://orcid.org/0000-0001-9969-8610, PMID:24026681] |
— |
HP:0004343 |
HPO |
HP:0410371 |
Increased hepatitis C virus antibody level |
"An abnormally increased level of immunoglobulin against hepatitis C virus in the blood." [] |
— |
HP:0010702 |
HPO |
HP:0410372 |
Increased Tn-antigen level |
"An abnormal increase in the concentration of Tn antigen on glycoproteins." [https://orcid.org/0000-0001-9969-8610, PMID:16251947] |
— |
HP:0012358 |
HPO |
HP:0410373 |
Abnormal proportion of naive CD4 T cells |
"Any abnormality in the proportion of naive CD4 T cells relative to the total number of T cells." [PMID:22474485] |
— |
HP:0031392, HP:0031396 |
HPO |
HP:0410374 |
Abnormal proportion of naive CD8 T cells |
"Any abnormality in the proportion of naive CD8 T cells relative to the total number of T cells." [PMID:26700072] |
— |
HP:0031396 |